Metastatic Melanoma: Symptoms, Stages, Treatment

Metastatic melanoma is an advanced form of melanoma. This subtype is one of the most dangerous types of skin cancer.
Melanoma begins in skin cells called melanocytes. Melanocytes produce melanin, the pigment that gives skin much of its color and provides some natural protection against ultraviolet radiation. These skin cells also produce moles, which are usually harmless but occasionally can become cancerous.
A melanoma can look like a mole. Melanoma is usually brown or black but can also be skin-colored, purple, blue, red, pink, or white.
Next up video playing in 10 seconds
What Are the Signs of Melanoma?
What Is Metastatic Melanoma, and How Does It Differ From Melanoma?
Melanoma is any cancer that originates in the melanocytes, while metastatic melanoma is melanoma that spreads from the skin to other parts of the body, such as the lymph nodes, liver, lungs, bones, and brain.
Causes and Risk Factors for Metastatic Melanoma
Everyone — of every age, sex, race, and ethnicity — faces some level of melanoma risk, including the metastatic kind, but certain factors raise the odds. These include:
Family History of Melanoma: Around 10 percent of people with melanoma have a first-degree family member with the disease, such as a parent, sibling, or child.
Personal History of Melanoma or Other Skin Cancers: Having had melanoma raises the risk of getting it again. Having another type of skin cancer, such as basal or squamous cell skin cancer, is also a risk factor.
Having a Weakened Immune System: People with conditions that weaken the immune system, such as HIV, are at higher risk of developing melanoma. People taking medication to suppress the immune system after an organ transplant are also at higher risk.
Advanced Age: Older people are more likely to develop melanoma than younger people. But younger people aren’t free of risk. In fact, melanoma is one of the most common cancers in people younger than 30.
Gender: Among people in the United States older than 50 years old, men are at a higher risk of developing melanoma than women. Before age 50, women are at greater risk.
What Are the Symptoms of Metastatic Melanoma?
Many people find out they have melanoma when symptoms prompt them to visit the doctor.
They may be concerned about a mole that is painful, itchy, or bleeding; that oozes or becomes scaly or lumpy; or that shows other signs of abnormality.
Doctors look for evidence of cancer in moles using what’s called the ABCDE method:
- A: It is asymmetrical.
- B: It has an irregular border.
- C: It contains more than one color or is an unusual color.
- D: Its diameter is unusually big, typically larger than 6 millimeters (mm), or ¼ inch.
- E: It evolves, changing size, color, shape, or another characteristic.
It’s possible that by the time a physician diagnoses melanoma on the skin, cancer cells have already spread to other parts of the body. Melanoma can also spread to a different part of the body after initial diagnosis and treatment.
Lymph Nodes
Symptoms of melanoma that has spread to the lymph nodes may include:
- Hard lumps under the skin
- Difficulty swallowing (because of swollen lymph nodes in the neck)
- Swelling in the neck or face (because of fluid buildup, a condition called lymphedema)
Lungs
Melanoma that has spread to the lungs can cause the following symptoms:
- A persistent cough
- Breathlessness
- Ongoing chest infections
- Coughing up blood
- Fluid buildup between the chest wall and the lung
Liver
Metastatic melanoma in the liver can cause:
- Discomfort or pain on the right side of the abdomen
- Poor appetite and weight loss
- Abdominal swelling
- Yellowing of the skin and eyes (jaundice)
- Itchy skin
Bone
The following symptoms may indicate metastatic melanoma:
- Gnawing pain (caused by the breakdown of bone)
- Worsening backache
- Weaker bones that break more easily
- Raised blood calcium, which can cause dehydration, confusion, abdominal pain, and constipation
- Low levels of blood cells (which are produced in healthy bone but crowded out by cancer cells), which can cause bruising, bleeding, and an increased risk of infection
Brain
Melanoma that has spread to the brain can cause:
- Headaches
- Muscle weakness
- Seizures
- Personality or mood changes
- Eyesight changes
- Confusion
Diagnosis of Metastatic Melanoma
During a physical exam, a doctor will examine any suspicious moles or areas of the skin for signs of melanoma. They will also ask about possible risk factors.
The physician may also feel the lymph nodes under the skin in the neck, underarm, groin, or behind the knees near the abnormal area to check for any unusual enlargement.
Next, the doctor will likely collect a skin sample from the area in question to study under a microscope for cancer cells. If the lab results confirm melanoma, physicians may take samples of other tissues, too, to check for metastases. In this case, the doctor may start with the lymph nodes nearest the primary skin lesion.
Imaging tests, such as X-rays or computerized tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET) scans, can also look for enlarged lymph nodes or cancerous spots on the lungs, liver, and other body parts.
In rare cases, melanoma metastasizes quickly, before the original tumor on the skin is large enough to be detected. In these cases, physicians may first biopsy tissue from an area of metastasis to figure out what type of cancer the patient has.
For instance, a biopsy may determine that cancerous spots on the liver are not liver cancer (cancer that originates in liver cells) but skin melanoma that has metastasized.
Stages of Metastatic Melanoma
Assigning a stage to a melanoma aims to describe how advanced the cancer is.
For patients with metastatic disease, determining the stage is crucial for identifying those who may be eligible for experimental treatments.
Stage 0
The melanoma is confined to the outermost layer of the skin; it has not spread.
Stage 1
The melanoma is no more than 2 mm thick and has not spread to lymph nodes or distant sites. Stage 1 is further divided according to tumor thickness and ulceration.
Stage 2
The melanoma has not spread to lymph nodes or distant sites but has features associated with higher risk, based primarily on its thickness and whether it is ulcerated, which is a sign of danger characterized by a breakdown of the skin over the tumor.
Stage 3
Stage 4
Metastatic Melanoma Treatment Options
Immunotherapy
Immunotherapy uses the body’s own powerful immune system to treat metastatic melanoma.
Another viable approach for using immunotherapy to treat metastatic melanoma is to combine checkpoint blockade therapies. Doing so may increase the chance of serious side effects, yet researchers are finding that this strategy can improve survival rates to such an extent that it’s a valuable option for some patients, despite the risks involved.
Targeted Therapies
A new generation of melanoma therapies works by targeting mutations (DNA defects) in melanoma cells, shrinking tumors or slowing their growth.
About one-half of all melanomas have mutations (DNA defects) in the BRAF gene that are responsible for out-of-control cellular growth.
These three combination therapies are now approved:
- dabrafenib (Tafinlar) and trametinib (Mekinist)
- vemurafenib (Zelboraf) and cobimetinib (Cotellic)
- encorafenib (Braftovi) and binimetinib (Mektovi)
Prognosis for Metastatic Melanoma
Until recent years, a metastatic melanoma prognosis gave patients very little reason to hope.
But since 2011, physicians have had access to remarkable new drugs that are helping many patients live significantly longer.
Many patients with metastatic melanoma are responding to the new treatments, extending their lives by months and years. Some are even going into long-term remission.
- Melanoma Overview. Skin Cancer Foundation. March 2026.
- Survival Rates for Melanoma Skin Cancer. American Cancer Society. August 12, 2026.
- Cancer Stat Facts: Melanoma of the Skin. National Cancer Institute.
- Melanoma Risk Factors. Skin Cancer Foundation. June 2021.
- Baigrie D, Tanner LS. Dysplastic Nevi. StatPearls. October 24, 2022.
- Large congenital melanocytic nevus. Genetic and Rare Diseases Information Center. June 2026.
- Wang S et al. Natural hair color and skin cancers: A two-sample Mendelian randomization study. Gene. January 30, 2024.
- Causes, Risk Factors, and Prevention of Melanoma Skin Cancer. American Cancer Society. August 12, 2026.
- Melanoma Warning Signs. Skin Cancer Foundation. March 2026.
- Symptoms of advanced melanoma skin cancer. Cancer Research UK. January 30, 2025.
- Tests for Melanoma Skin Cancer. American Cancer Society. August 12, 2026.
- Melanoma Treatment (PDQ®)–Patient Version. National Cancer Institute. May 16, 2025.
- Stages of Melanoma Skin Cancer. American Cancer Society. August 12, 2026.
- Chemotherapy for Melanoma Skin Cancer. American Cancer Society. August 12, 2026.
- Lee JB et al. Immune Checkpoint Inhibitors in 10 Years: Contribution of Basic Research and Clinical Application in Cancer Immunotherapy. Immune Network. February 14, 2022.
- Jimmy Carter’s Melanoma Appears to Respond to Immunotherapy. American Association for Cancer Research.
- Pembrolizumab May Help Prevent Early-Stage Melanoma from Returning. National Cancer Institute. October 13, 2021.
- Long GV et al. Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study. Annals of Oncology. December 2024.
- Wolchok JD et al. Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. The New England Journal of Medicine. January 2, 2025.
- Wolchok JD et al. Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. The New England Journal of Medicine. January 6, 2022.
- FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma. U.S. Food and Drug Administration. August 6, 2026.
- Ellebaek E et al. Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study. EJC Skin Cancer. 2026.
- Understanding Melanoma Treatment. Skin Cancer Foundation. August 2026.

Blair Murphy-Rose, MD
Medical Reviewer
Blair Murphy-Rose, MD, is a board-certified dermatologist in New York City and the founder of Skincare Junkie. She is an accomplished cosmetic, medical, and surgical dermatologist,...

Pamela Kaufman
Author
Pamela Kaufman assigns and edits stories about infectious diseases and general health topics and strategizes on news coverage. She began her journalism career as a junior editor on...